Population based survey on the NTM pulmonary disease treatment in Japan

K. Izumi (Tokyo, Japan), K. Morimoto (Tokyo, Japan), K. Uchimura (Tokyo, Japan), M. Ato (Tokyo, Japan), S. Mitarai (Tokyo, Japan), N. Hasegawa (Tokyo, Japan)

Source: International Congress 2018 – The global impact of bronchiectasis and nontuberculous mycobacteria (NTM)
Session: The global impact of bronchiectasis and nontuberculous mycobacteria (NTM)
Session type: Poster Discussion
Number: 346
Disease area: Respiratory infections

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Izumi (Tokyo, Japan), K. Morimoto (Tokyo, Japan), K. Uchimura (Tokyo, Japan), M. Ato (Tokyo, Japan), S. Mitarai (Tokyo, Japan), N. Hasegawa (Tokyo, Japan). Population based survey on the NTM pulmonary disease treatment in Japan. 346

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: